Patients’ Demographic Data
| Participant | Age (y) | Sex | BMI (kg/m2) | Diagnosis | Therapy | Radiotracer dose (GBq) |
|---|---|---|---|---|---|---|
| 1 | 52 | M | 20.6 | Rectal NET | PRRT | 3.70 |
| 2 | 58 | M | 24.9 | Midgut NET | PRRT | 3.70 |
| 3 | 39 | M | 19.2 | Paraganglioma | PRRT | 4.22 |
| 4 | 54 | F | 21.8 | Midgut NET metastatic to liver | PRRT | 3.03 |
| 5 | 41 | M | 19.7 | Pancreatic NET metastatic to liver | SIRT | 2.97 |
| 6 | 68 | M | 25.9 | HCC | SIRT | 1.30 |
| 7 | 69 | M | 26.1 | HCC | SIRT | 0.58 |
| 8 | 59 | M | 29.9 | HCC | SIRT | 2.50 |
| 9 | 96 | M | 25.9 | HCC | SIRT | 0.73 |
| 10 | 79 | F | 21.4 | HCC | SIRT | 3.00 |
BMI = body mass index; NET = neuroendocrine tumor; HCC = hepatocellular carcinoma.